David I. Bellovin
Academic Appointments
- Postdoctoral Research fellow, Medicine
Contact Information
- Academic
Offices
Personal Information Email
Professional Snapshot
Honors and Awards
- Student of the Year, Department of Molecular and Cellular Biology, University of Arizona (2000)
- B.S., Magna Cum Laude with Honors, University of Arizona (2000)
- BCRP Predoctoral Fellow, US Dept. of Defense (2003-2006)
- NRSA Postdoctoral Fellow, NIH/NCI (2008)
Professional Education
| Doctor of Philosophy: | Harvard University, (2006) |
Faculty Advisor
Scientific Focus
Current Research Interests
Currently investigating the origin, development, and treatment of MYC-induced hepatocellular carcinoma using a conditional transgenic mouse model.
Publications
- Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice. Mol Ther. 2010; (1): 161-70
- Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis. PLoS One. 2008; (6): e2493
- Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. PLoS One. 2008; (5): e2125
- Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene. 2006; (52): 6959-67
- Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005; (2): 339-47
Help
Trial Administration